| Name | Title | Contact Details |
|---|
Sampling Technologies - STI Smart Technologies is a Lower Sackville, NS-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Human Development Center is a Duluth, MN-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Dudnyk Healthcare Group is a Horsham, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Affinity Health Plan is an independent, not-for-profit organization offering low cost, quality health care coverage to underserved New Yorkers. Its programs are sponsored by New York State and include Child Health Plus, Family Health Plus, Medicaid managed care, and Medicare. Founded in 1986, Affinity serves more than 275,000 members in New York City, Long Island, and the surrounding counties of Westchester, Rockland and Orange.
OncoGenex is a biopharmaceutical company committed to the development and commercialization of new therapies that address treatment resistance in cancer patients. OncoGenex has a diverse oncology pipeline, with each product candidate having a distinct mechanism of action and representing a unique opportunity for cancer drug development. OncoGenex and Teva Pharmaceutical Industries Ltd. have entered a global collaboration and licensing agreement to develop and commercialize OncoGenex' lead drug candidate, custirsen. Custirsen is currently in Phase 3 clinical development as a treatment in men with metastatic castrate-resistant prostate cancer and in patients with advanced, unresectable non-small cell lung cancer. Apatorsen is in Phase 2 clinical development and OGX-225 is currently in pre-clinical development.